Sign inGet started

Nikolaou Anastasis

Insider CIK 1954186 · ACRV 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ACRV Acrivon Therapeutics, Inc. S Sale2023-06-262023-06-2816$12.93 $2073,848,632SEC↗
ACRV Acrivon Therapeutics, Inc. S Sale2023-06-152023-06-202,056$12.14 $25.0K3,848,648SEC↗
ACRV Acrivon Therapeutics, Inc. S Sale2023-06-142023-06-14893$12.13 $10.8K3,850,704SEC↗
ACRV Acrivon Therapeutics, Inc. S Sale2023-06-132023-06-143,000$12.30 $36.9K3,851,597SEC↗
ACRV Acrivon Therapeutics, Inc. S Sale2023-06-122023-06-142,000$12.34 $24.7K3,854,597SEC↗
ACRV Acrivon Therapeutics, Inc. C Conversion deriv2022-11-172022-11-2126,281— $00SEC↗
ACRV Acrivon Therapeutics, Inc. C Conversion deriv2022-11-172022-11-218,497,692— $00SEC↗
ACRV Acrivon Therapeutics, Inc. C Conversion2022-11-172022-11-213,445,940— $03,856,597SEC↗
ACRV Acrivon Therapeutics, Inc. C Conversion2022-11-172022-11-2110,657— $03,856,597SEC↗
ACRV Acrivon Therapeutics, Inc. P Buy2022-11-172022-11-21400,000$12.50 $5.00M3,856,597SEC↗